Results 231 to 240 of about 242,018 (254)

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

New England Journal of Medicine, 2018
Jennifer A Woyach, Amy S Ruppert, Wei Ding   +2 more
exaly  

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

New England Journal of Medicine, 2014
Javier De La Serna, Stephen Opat, Stephan Stilgenbauer   +2 more
exaly  

Ibrutinib and Venetoclax for First-Line Treatment of CLL

New England Journal of Medicine, 2019
Nitin Jain, Michael Keating, Jan A Burger   +2 more
exaly  

Mutations driving CLL and their evolution in progression and relapse

Nature, 2015
Eugen Tausch, Amaro N Taylor-Weiner, Chip Stewart   +2 more
exaly  

Venetoclax–obinutuzumab combinations are effective in fit patients with CLL

Nature Reviews Clinical Oncology, 2023
exaly  

Combination therapies for previously untreated CLL

Lancet, The, 2007
Neil E Kay
exaly  

CLL

Oncology Times, 2015
openaire   +1 more source

CML as a Second Cancer after CLL

Ca-A Cancer Journal for Clinicians, 1981
exaly  

Editor's Reply: H. G. Wells on Cancer

Ca-A Cancer Journal for Clinicians, 1981
exaly  

CLL

Oncology Times, 2006
openaire   +1 more source